{"id":8215,"date":"2024-07-09T08:19:03","date_gmt":"2024-07-09T08:19:03","guid":{"rendered":"https:\/\/shoonya.com\/blog\/?p=8215"},"modified":"2025-06-05T12:40:55","modified_gmt":"2025-06-05T12:40:55","slug":"sebi-approved-upcoming-ipos","status":"publish","type":"post","link":"https:\/\/shoonya.com\/blog\/sebi-approved-upcoming-ipos\/","title":{"rendered":"SEBI Approves Upcoming IPOs of Akums Drugs, Gold Plus Glass, Ceigall India & Orient Technologies"},"content":{"rendered":"
Home<\/a><\/span> \u00bb Investing<\/a><\/span> \u00bb IPO<\/a><\/span> \u00bb SEBI Approves Upcoming IPOs of Akums Drugs, Gold Plus Glass, Ceigall India & Orient Technologies<\/strong><\/span><\/span><\/div>\n\n\n

<\/p>\n\n\n\n

The stock market regulator, SEBI has approved four new and upcoming IPOs <\/strong>in the past week as announced yesterday 8 July 2024. The companies, that got the go-ahead from SEBI, include Akums Drugs and Pharmaceuticals, Gold Plus Glass Industry, Orient Technologies, and Ceigall India. All four companies after waiting for five months as they filed their draft red herring prospectus (DRHP) <\/strong>in February 2024 are now eligible to float their initial public offering<\/strong>. <\/p>\n\n\n\n

Upcoming IPO Details<\/strong><\/h2>\n\n\n\n
    \n
  1. Akums Drugs and Pharmaceuticals:<\/strong> According to the DRHP of Akums Drugs, this IPO is going to be a mix of both a fresh equity share issue and an offer for sale (OFS). Equity shares worth \u20b9 680 crore will be offered while 1.86 crore shares will be offered by promoters and existing investors as OFS. The selling promoters and investors include Sandeep Jain Sanjeev Jain and Ruby QC Investment Holdings. The proceeds of the fresh equity issues of akums drugs ipo<\/strong> will be used for debt repayment, as working capital, general corporate expenses, and boost inorganic growth initiatives.\u00a0<\/li>\n\n\n\n
  2. Gold Plus Glass Industry:<\/strong> The next on the list of these upcoming IPOs<\/strong> is Gold Plus Glass Industry which is also coming up with gold plus glass ipo<\/strong> that\u2019s a combination of a fresh issue and an offer for the same. Equity shares worth \u20b9 500 crore will be issued as fresh issues while 1.56 crore shares will be offered under OFS from promoters and investors such as Suresh Tyagi, Jimmy Tyagi, PI Opportunities, and others. This float glassmaker has around 22% of the market share when it comes to the manufacturing capacity of these float glasses. The sectors it caters to include construction, automotive, industrial sector, and others.\u00a0<\/li>\n\n\n\n
  3. Ceigall India IPO:<\/strong> This infrastructure construction company has been coming up with \u20b9 617.69 crore fresh issue and 1.43 crore equity shares as offers for sale. The company is engaged in the construction of roads, bridges, tunnels, flyovers, and other infrastructure. NHAI contributes to a major portion of the order book of Ceigall India and during January 2024, the order book stood at \u20b9 9206.42 crores.\u00a0<\/li>\n\n\n\n
  4. Orient Technologies:<\/strong> This IT firm also coming up with a combination of fresh issues and OFS. The Orient Technologies ipo<\/strong> will include a fresh issue of around \u20b9 120 crores while OFS will have 46 lakh equity shares. This IT firm specializes in developing solutions for the specialized discipline of IT infrastructure, cloud and data management, and IT-enabled services. The promoters and existing investors who are offloading their shares include Jayesh Manharlal Shah, Umesh Navnital Shah, Ajay Baliram Sawant, and Ujwal Arving Mhatre.<\/li>\n<\/ol>\n\n\n\n

    The duration for IPOs approval from SEBI has come down thus helping companies get approvals within a short period. The dates and other IPO details of these upcoming IPOs<\/strong> will be announced shortly, and for the same keep track of ipo news<\/strong>. All these companies will get listed both on BSE and NSE.\u00a0<\/p>\n\n\n\n

    Source: <\/strong>https:\/\/moneycontrol.com<\/mark><\/a><\/p>\n\n\n\n

    ______________________________________________________________________________________<\/p>\n\n\n\n

    Disclaimer<\/mark><\/a>: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.<\/p>\n\n\n\n

    <\/p>\n\r\n